BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21545376)

  • 1. Clinical severity of haemophilia A: does the classification of the 1950s still stand?
    Den Uijl IE; Mauser Bunschoten EP; Roosendaal G; Schutgens RE; Biesma DH; Grobbee DE; Fischer K
    Haemophilia; 2011 Nov; 17(6):849-53. PubMed ID: 21545376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels.
    den Uijl IE; Fischer K; Van Der Bom JG; Grobbee DE; Rosendaal FR; Plug I
    Haemophilia; 2011 Jan; 17(1):41-4. PubMed ID: 20825504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed.
    van Dijk K; Fischer K; van der Bom JG; Grobbee DE; van den Berg HM
    Haemophilia; 2005 Sep; 11(5):438-43. PubMed ID: 16128885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of differences in annual factor VIII utilization among haemophilia A patients.
    Epstein J; Xiong Y; Woo P; Li-McLeod J; Spotts G
    Haemophilia; 2012 Mar; 18(2):187-92. PubMed ID: 21883704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous clotting factor activity and long-term outcome in patients with moderate haemophilia.
    Fischer K; van der Bom JG; Mauser-Bunschoten EP; Roosendaal G; Beek FJ; de Kleijn P; Grobbee DE; van den Berg HM
    Thromb Haemost; 2000 Dec; 84(6):977-80. PubMed ID: 11154144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing patterns of bleeding in patients with severe haemophilia A.
    Stephensen D; Tait RC; Brodie N; Collins P; Cheal R; Keeling D; Melton K; Dolan G; Haye H; Hayman E; Winter M
    Haemophilia; 2009 Nov; 15(6):1210-4. PubMed ID: 19659938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar bleeding phenotype in young children with haemophilia A or B: a cohort study.
    Clausen N; Petrini P; Claeyssens-Donadel S; Gouw SC; Liesner R;
    Haemophilia; 2014 Nov; 20(6):747-55. PubMed ID: 24893572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials.
    Fischer K; Collins P; Björkman S; Blanchette V; Oh M; Fritsch S; Schroth P; Spotts G; Ewenstein B
    Haemophilia; 2011 May; 17(3):433-8. PubMed ID: 21299740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet degranulation and glycoprotein IIbIIIa opening are not related to bleeding phenotype in severe haemophilia A patients.
    van Bladel ER; Schutgens RE; Fischer K; de Groot PG; Roest M
    Thromb Haemost; 2014 Jun; 111(6):1022-30. PubMed ID: 24477967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
    Taki M; Shirahata A
    Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of moderate haemophilia compared with severe and mild haemophilia.
    den Uijl IE; Fischer K; Van Der Bom JG; Grobbee DE; Rosendaal FR; Plug I
    Haemophilia; 2009 Jan; 15(1):83-90. PubMed ID: 18713246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
    Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
    Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life.
    Khawaji M; Astermark J; Berntorp E
    Eur J Haematol; 2012 Apr; 88(4):329-35. PubMed ID: 22221195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint health scores in a haemophilia A cohort from Pakistan with minimal or no access to factor VIII concentrate: correlation with thrombin generation and underlying mutation.
    Khanum F; Bowen DJ; Kerr BC; Collins PW
    Haemophilia; 2014 May; 20(3):426-34. PubMed ID: 24354535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent increase of FVIII:C in mild haemophilia A.
    Miesbach W; Alesci S; Krekeler S; Seifried E
    Haemophilia; 2009 Sep; 15(5):1022-6. PubMed ID: 19493020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment.
    Den Uijl I; Mauser-Bunschoten EP; Roosendaal G; Schutgens R; Fischer K
    Haemophilia; 2009 Nov; 15(6):1215-8. PubMed ID: 19686467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.
    Trossaert M; Lienhart A; Nougier C; Fretigny M; Sigaud M; Meunier S; Fouassier M; Ternisien C; Negrier C; Dargaud Y
    Haemophilia; 2014 Jul; 20(4):550-8. PubMed ID: 24517184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between phenotype and genotype in carriers of haemophilia A.
    Miesbach W; Alesci S; Geisen C; Oldenburg J
    Haemophilia; 2011 Mar; 17(2):246-51. PubMed ID: 21118332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When is severe haemophilia A diagnosed in children and when do they start to bleed? Re-evalution after 10 years of experience].
    Pollmann H; Siegmund B; Richter H
    Hamostaseologie; 2010 Nov; 30 Suppl 1():S112-4. PubMed ID: 21042674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.